Japan Cancer Research Youming Hospital is the number one cancer hospital in Japan and the world's leading cancer center. Kanyan Youming Hospital is located in jiangdong district, Tokyo. The hospital has always been the best in the treatment of gastric cancer, colorectal cancer, breast cancer and prostate cancer in Japan, and also ranks among the top three in the treatment of other adult cancers such as liver cancer and lung cancer in Japan. Since its establishment, it has been committed to the research and development of the most cutting-edge cancer treatment technology, and has the world's advanced diagnosis and treatment technology, which has been promoting the innovation in the field of cancer treatment technology in Japan and even the world.
The National Cancer Research Center of Japan was established in 196 1, located in the center of Tokyo. The National Cancer Research Center is a comprehensive center integrating cancer treatment, cancer prevention and research. It is a specialized cancer hospital in Japan, second only to Youming Hospital for Cancer Research. The National Cancer Center is divided into East Hospital and Central Hospital. The East Hospital has advanced proton therapy equipment in the world, which is where the National Cancer Center is ahead of the Cancer Research Hospital. With proton therapy equipment, the National Cancer Center has obvious advantages in the treatment of skull base tumors, nose and sinus tumors, nasopharyngeal carcinoma, early prostate cancer, early lung cancer, liver cancer and other cancers.
Hyogo particle line therapy center was established in 200 1 year, which is the only medical institution in the world that can carry out proton line therapy and heavy particle line therapy, and is famous for its remarkable therapeutic effect. Since the establishment of this facility, more than 4,500 patients have been treated, and now more than 65,438+000 patients can be treated in this facility every day. Since the treatment of pancreatic cancer began in February 2009, more than 265,438+00 patients have been treated. So far, the center has received overseas patients from Thailand, China, South Korea and Italy, and accumulated experience in cooperation with local medical institutions.
Professor Masahiro Hiraoka of the Department of Radiotherapy of the Affiliated Hospital of Kyoto University School of Medicine is a famous cancer radiotherapy expert and a pioneer of high-precision radiotherapy. Clinical research on high-precision radiotherapy for solitary lung tumor and IMRT for prostate cancer has been carried out in China for a long time. With the ultimate goal of curing all cancers without surgery and allowing patients to enjoy normal life again, a new type of radiotherapy device that can accurately irradiate lesions according to respiratory movements has been successfully developed. For prostate cancer, "hormone pretreatment +IMRT" has little side effects and achieved good results.
The Proton Line Therapy Center of the Affiliated Hospital of Tsukuba University started the first clinical study of proton line therapy in Japan on 1983, and its proton line medical utilization research center was opened in September 20001,which is the only proton line therapy facility in Japan. Including the treatment of high-energy accelerator research institutions before the opening of the center, the number of cases treated has reached about 3000. Among them, the most common is liver cancer, with nearly 1 000 cases, followed by lung cancer and prostate cancer. "Respiratory synchrotron radiotherapy" is an irradiation method developed by the center and has become an international standard. The advent of this technology makes it possible to treat liver cancer and lung cancer with proton rays.
Kameda Medical Center is the general name of Kameda Clinic and Kameda Rehabilitation Hospital centered on Kameda General Hospital. In 2009, it was certified by JCI International Joint Committee for the first time. We have been actively receiving overseas patients for a long time, taking the "International Relations Department" as the service window, and are responsible for arranging medical appointments, contacting insurance companies and other businesses, and answering questions about study, training and follow-up reception. The center has enriched the environmental conditions for receiving foreign patients, and the number of overseas consultations has increased year by year, receiving about 1200 foreign patients every year. The characteristic of cancer treatment in this center is that a team composed of various experts comprehensively carries out three standard therapies: surgery, radiotherapy and chemotherapy in time and correctly. Adopt a high-level team medical treatment led by a few oncologists in Asia. The center also gives full play to the advantages of general hospitals. For cancer patients with heart disease, cerebrovascular disease, respiratory diseases and other complications, or elderly cancer patients with various complications, experts from various disciplines consult and cooperate closely to carry out comprehensive, safe and effective treatment.
The Proton Beam Therapy Center of Hokkaido University Hospital, under the cutting-edge research support system aiming at the world's top-level "most advanced technology research and development support project", has jointly developed proton therapy equipment leading the development of cancer radiotherapy technology in the world with Hokkaido University and Hitachi Co., Ltd. ... Our proton beam therapy center is the first in the world to introduce the most advanced proton therapy equipment "spot scanning proton beam irradiation special plane", which can accurately irradiate active cancer in 360 degrees, and can treat all ages with spot scanning irradiation technology.
The affiliated hospital of Chiba University School of Medicine is a recognized cancer hospital in Japan, with perfect technology and strong strength. The admitted patients come from all over Japan and play the role of core medical institutions. In particular, we actively carry out the treatment of refractory tumors, carry out difficult operations in the field of hepatobiliary and pancreatic surgery, and devote ourselves to clinical and basic research. The number of cases treated was 1 1, ranking first in Japan and second in the world, and the treatment results were highly praised by medical circles at home and abroad. It is one of the earliest hospitals in Japan to treat esophageal cancer. The hospital is committed to the research and development of immunotherapy for NKT cell tumors, and has set up a clinical application center in the hospital to lead the trend of immunotherapy in the world. Our hospital has been approved by the Ministry of Health, Labor and Welfare as a hospital to carry out advanced medical treatment for refractory cancers such as lung cancer, oral cancer in the field of head and neck, laryngeal cancer and pharyngeal cancer, and has treated 8 cancer patients.
Gunma County Heavy Particle Line Medical Center Gunma University opened the Heavy Ion Line Medical Research Center of Gunma University on June 1 2005, aiming at developing cutting-edge heavy ion beam therapy based on radiobiology and clinical research and realizing the required treatment technology, aiming at smoothly promoting the comprehensive research of heavy ion line medicine. Gunma University has always been a leader in radiation oncology and nuclear medicine in Japan. In particular, it also plays an important role in training radiologists for radiation tumor treatment. 65,438+00% of certified radiotherapy doctors in Japan come from the radiology department of universities. In addition, the Institute has maintained close cooperation with IRRI, a representative institution of radiation utilization in Japan, and Takasaki Institute of Quantum Applications (formerly Takasaki Institute), a research and development institute of atomic energy in Japan.